| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BNGOBionano Genomics, Inc. | 15.47M | 1.52 | -0.02 | -14.79% | -134.36% | -77.49% | 0.77 | |
| ATLNAtlantic International Corp. | 135.19M | 2.31 | -0.63 | 10.27% | -22.66% | |||
| ILMNIllumina, Inc. | 22.2B | 145.30 | -18.89 | -2.93% | 16.4% | 29.53% | 3.19% | 1.10 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 6.79M | 9.51M | 12M | 10.13M | 8.5M | 17.98M | 27.8M | 36.12M | 30.78M |
| Revenue Growth % | - | 0.4% | 0.26% | -0.16% | -0.16% | 1.11% | 0.55% | 0.3% | -0.15% |
| Cost of Goods Sold | 3.58M | 6.03M | 8.71M | 6.77M | 5.73M | 14.11M | 21.86M | 26.55M | 30.4M |
| COGS % of Revenue | 0.53% | 0.63% | 0.73% | 0.67% | 0.67% | 0.78% | 0.79% | 0.74% | 0.99% |
| Gross Profit | 3.21M | 3.47M | 3.29M | 3.36M | 2.77M | 3.87M | 5.95M | 9.57M | 380K |
| Gross Margin % | 0.47% | 0.37% | 0.27% | 0.33% | 0.33% | 0.22% | 0.21% | 0.26% | 0.01% |
| Gross Profit Growth % | - | 0.08% | -0.05% | 0.02% | -0.18% | 0.4% | 0.53% | 0.61% | -0.96% |
| Operating Expenses | 24.38M | 26.09M | 23.7M | 29.24M | 41.32M | 80.97M | 137.64M | 224.81M | 104.36M |
| OpEx % of Revenue | 3.59% | 2.74% | 1.98% | 2.89% | 4.86% | 4.5% | 4.95% | 6.22% | 3.39% |
| Selling, General & Admin | 12.95M | 14.08M | 14.22M | 20.16M | 0 | 58.49M | 88.6M | 94.96M | 51.85M |
| SG&A % of Revenue | 1.91% | 1.48% | 1.18% | 1.99% | - | 3.25% | 3.19% | 2.63% | 1.68% |
| Research & Development | 11.43M | 12.01M | 9.48M | 9.08M | 10.26M | 22.48M | 49.05M | 54.03M | 24.8M |
| R&D % of Revenue | 1.68% | 1.26% | 0.79% | 0.9% | 1.21% | 1.25% | 1.76% | 1.5% | 0.81% |
| Other Operating Expenses | -203.28K | 0 | 0 | 0 | 31.07M | 0 | -223K | 75.82M | 27.7M |
| Operating Income | -21.17M | -23.22M | -20.42M | -25.87M | -38.55M | -77.1M | -131.7M | -215.25M | -103.98M |
| Operating Margin % | -3.12% | -2.44% | -1.7% | -2.55% | -4.53% | -4.29% | -4.74% | -5.96% | -3.38% |
| Operating Income Growth % | - | -0.1% | 0.12% | -0.27% | -0.49% | -1% | -0.71% | -0.63% | 0.52% |
| EBITDA | -20.05M | -21.71M | -19.09M | -24.75M | -37.07M | -73.73M | -121.6M | -201.54M | -89.76M |
| EBITDA Margin % | -2.95% | -2.28% | -1.59% | -2.44% | -4.36% | -4.1% | -4.37% | -5.58% | -2.92% |
| EBITDA Growth % | - | -0.08% | 0.12% | -0.3% | -0.5% | -0.99% | -0.65% | -0.66% | 0.55% |
| D&A (Non-Cash Add-back) | 1.12M | 1.5M | 1.32M | 1.13M | 1.48M | 3.37M | 10.1M | 13.71M | 14.23M |
| EBIT | -18.37M | -22.76M | -17.1M | -27.51M | -37.05M | -77.22M | -130.41M | -227.31M | -111.69M |
| Net Interest Income | -470.07K | -590.93K | -1.38M | -2.29M | -2.52M | -691K | 1.21M | -1.81M | 1.81M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 236K | 1.51M | 3.31M | 2.1M |
| Interest Expense | 470.07K | 590.93K | 1.38M | 2.29M | 2.52M | 927K | 298K | 5.12M | 289K |
| Other Income/Expense | 2.33M | -128K | 1.93M | -3.92M | -2.53M | -1.05M | 986K | -17.19M | -8M |
| Pretax Income | -18.84M | -23.35M | -18.48M | -29.79M | -41.08M | -78.15M | -130.71M | -232.43M | -111.98M |
| Pretax Margin % | -2.77% | -2.46% | -1.54% | -2.94% | -4.83% | -4.35% | -4.7% | -6.44% | -3.64% |
| Income Tax | 12.92K | 18.55K | 15.51K | 21.05K | 29K | -5.72M | 1.88M | 62K | 33K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 0.93% | 1.01% | 1% | 1% |
| Net Income | -18.85M | -23.37M | -18.5M | -29.82M | -41.11M | -72.44M | -132.6M | -232.49M | -112.02M |
| Net Margin % | -2.77% | -2.46% | -1.54% | -2.94% | -4.83% | -4.03% | -4.77% | -6.44% | -3.64% |
| Net Income Growth % | - | -0.24% | 0.21% | -0.61% | -0.38% | -0.76% | -0.83% | -0.75% | 0.52% |
| Net Income (Continuing) | -18.85M | -23.37M | -18.5M | -29.82M | -41.11M | -72.44M | -132.6M | -232.49M | -112.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | 0.00 | -94089.60 | -71662.20 | -14194.80 | -9421.20 | -16505.40 | -24516.00 | -88.13 |
| EPS Growth % | - | - | - | 0.24% | 0.8% | 0.34% | -0.75% | -0.49% | 1% |
| EPS (Basic) | 0.00 | 0.00 | -94089.60 | -71662.20 | -14194.80 | -9421.20 | -16505.40 | -24508.80 | -88.13 |
| Diluted Shares Outstanding | 0 | 0 | 201 | 424 | 177.23K | 470.53K | 491.66K | 580.55K | 1.9M |
| Basic Shares Outstanding | 0 | 0 | 201 | 424 | 177.23K | 470.53K | 491.66K | 580.38K | 1.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 10.74M | 7.14M | 23.03M | 28.26M | 46.79M | 272.41M | 157.3M | 140.12M | 39.49M |
| Cash & Short-Term Investments | 5.25M | 1.02M | 16.52M | 17.31M | 38.45M | 250.61M | 113.19M | 66.77M | 9.47M |
| Cash Only | 5.25M | 1.02M | 16.52M | 17.31M | 38.45M | 24.57M | 5.09M | 17.95M | 9.17M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 226.04M | 108.09M | 48.82M | 302K |
| Accounts Receivable | 1.85M | 3.35M | 4.51M | 6.33M | 2.77M | 5.32M | 7.5M | 9.66M | 4.77M |
| Days Sales Outstanding | 99.22 | 128.73 | 137.3 | 228.23 | 119.12 | 108.01 | 98.41 | 97.64 | 56.62 |
| Inventory | 1.8M | 1.69M | 1.07M | 3.44M | 3.31M | 12.39M | 29.76M | 22.89M | 11.12M |
| Days Inventory Outstanding | 183.32 | 102.51 | 44.77 | 185.71 | 211.16 | 320.5 | 496.99 | 314.71 | 133.54 |
| Other Current Assets | 802.5K | 550.06K | 458.82K | 457.06K | 462K | 1.38M | 2.41M | 36.09M | 12.32M |
| Total Non-Current Assets | 4.05M | 3.01M | 1.78M | 1.95M | 13.66M | 104.69M | 150.2M | 74.28M | 37.18M |
| Property, Plant & Equipment | 4.05M | 3.01M | 1.78M | 1.95M | 4.91M | 20.93M | 28.96M | 32.48M | 24.32M |
| Fixed Asset Turnover | 1.68x | 3.16x | 6.75x | 5.20x | 1.73x | 0.86x | 0.96x | 1.11x | 1.27x |
| Goodwill | 0 | 0 | 0 | 0 | 7.17M | 56.16M | 77.29M | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 1.48M | 26.84M | 41.14M | 33.97M | 9.71M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 103K | 749K | 2.81M | 7.83M | 3.15M |
| Total Assets | 14.79M | 10.15M | 24.8M | 30.21M | 60.45M | 377.1M | 307.5M | 214.4M | 76.67M |
| Asset Turnover | 0.46x | 0.94x | 0.48x | 0.34x | 0.14x | 0.05x | 0.09x | 0.17x | 0.40x |
| Asset Growth % | - | -0.31% | 1.44% | 0.22% | 1% | 5.24% | -0.18% | -0.3% | -0.64% |
| Total Current Liabilities | 9.36M | 16.65M | 4.52M | 26.37M | 8.95M | 21.84M | 35.88M | 100.03M | 37.34M |
| Accounts Payable | 792.33K | 2.3M | 1.35M | 2.7M | 2.93M | 10.77M | 12.53M | 10.38M | 6.96M |
| Days Payables Outstanding | 80.81 | 139.39 | 56.64 | 145.56 | 186.64 | 278.63 | 209.31 | 142.76 | 83.6 |
| Short-Term Debt | 587.13K | 6.73M | 0 | 20.08M | 0 | 0 | 0 | 69.8M | 20.36M |
| Deferred Revenue (Current) | 446.77K | 211.7K | 271K | 357.49K | 416K | 1000K | 888K | 800K | 1000K |
| Other Current Liabilities | 6.9M | 3.9M | 2.13M | 2.07M | 3.36M | 4.53M | 16.38M | 13.96M | 3M |
| Current Ratio | 1.15x | 0.43x | 5.09x | 1.07x | 5.23x | 12.47x | 4.38x | 1.40x | 1.06x |
| Quick Ratio | 0.95x | 0.33x | 4.85x | 0.94x | 4.86x | 11.91x | 3.55x | 1.17x | 0.76x |
| Cash Conversion Cycle | 201.73 | 91.85 | 125.44 | 268.38 | 143.64 | 149.88 | 386.09 | 269.59 | 106.56 |
| Total Non-Current Liabilities | 32.68M | 43.72M | 10.14M | 227.13K | 16.42M | 18.14M | 22.22M | 18.22M | 3.95M |
| Long-Term Debt | 6.05M | 0 | 9.03M | 0 | 16.32M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | -25.42M | 0 | 0 | 0 | 0 | 8.93M | 9.12M | 7.17M | 3.68M |
| Deferred Tax Liabilities | 25.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -24.44M | 43.58M | 808.37K | 44.48K | 0 | 9.07M | 12.97M | 10.89M | 0 |
| Total Liabilities | 42.05M | 60.37M | 14.67M | 26.59M | 25.37M | 39.98M | 58.1M | 118.25M | 41.3M |
| Total Debt | 6.63M | 6.73M | 9.03M | 20.08M | 16.32M | 10.7M | 11.67M | 79.41M | 27.3M |
| Net Debt | 1.38M | 5.71M | -7.49M | 2.77M | -22.12M | -13.88M | 6.58M | 61.47M | 18.12M |
| Debt / Equity | - | - | 0.89x | 5.56x | 0.47x | 0.03x | 0.05x | 0.83x | 0.77x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -45.03x | -39.29x | -14.78x | -11.32x | -15.30x | -83.17x | -441.94x | -42.05x | -359.80x |
| Total Equity | -27.26M | -50.23M | 10.14M | 3.61M | 35.08M | 337.12M | 249.4M | 96.16M | 35.38M |
| Equity Growth % | - | -0.84% | 1.2% | -0.64% | 8.71% | 8.61% | -0.26% | -0.61% | -0.63% |
| Book Value per Share | - | - | 50556.57 | 8515.47 | 197.95 | 716.46 | 507.26 | 165.63 | 18.59 |
| Total Shareholders' Equity | -27.26M | -50.23M | 10.14M | 3.61M | 35.08M | 337.12M | 249.4M | 96.16M | 35.38M |
| Common Stock | 7 | 8 | 1K | 3.43K | 19K | 29K | 3K | 0 | 0 |
| Retained Earnings | -30.9M | -54.27M | -72.76M | -102.58M | -143.68M | -216.12M | -348.71M | -581.21M | -693.23M |
| Treasury Stock | 0 | -4.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.42M | -3.92M | -5.16M | 0 | 0 | -539K | -1.12M | 23K | 27K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -23.5M | -20.82M | -19.94M | -29.53M | -38.31M | -71.93M | -124.82M | -125.18M | -68.92M |
| Operating CF Margin % | -3.46% | -2.19% | -1.66% | -2.92% | -4.51% | -4% | -4.49% | -3.47% | -2.24% |
| Operating CF Growth % | - | 0.11% | 0.04% | -0.48% | -0.3% | -0.88% | -0.74% | -0% | 0.45% |
| Net Income | -18.85M | -23.37M | -18.5M | -29.82M | -41.11M | -72.44M | -132.6M | -232.49M | -112.02M |
| Depreciation & Amortization | 1.12M | 1.5M | 1.32M | 1.13M | 1.48M | 3.37M | 9.84M | 13.91M | 14.23M |
| Stock-Based Compensation | 130.64K | 382.83K | 1.31M | 1.35M | 1.55M | 9.72M | 22.42M | 15.18M | 9.74M |
| Deferred Taxes | -3.01M | 479.01K | -2.46M | 1.9M | 0 | -5.78M | 1.76M | 0 | 0 |
| Other Non-Cash Items | 73.9K | 96.58K | 750.47K | 883.27K | 3.2M | 848K | 1.7M | 92.99M | 14.73M |
| Working Capital Changes | -2.96M | 85.1K | -2.37M | -4.97M | -3.44M | -7.65M | -27.94M | -14.77M | 4.4M |
| Change in Receivables | -856.1K | -1.77M | -900.12K | -2.37M | 2.09M | -493K | -2.25M | -2.3M | 4.14M |
| Change in Inventory | -726.14K | -336.05K | -418.98K | -3.64M | -4.2M | -15.93M | -23.68M | -4.15M | -587K |
| Change in Payables | -608.65K | 1.54M | -954.38K | 1.36M | -1.81M | 6.78M | 1.95M | -2M | -3.42M |
| Cash from Investing | -1.35M | -1.02M | -331.72K | -61.06K | -2.45M | -278.06M | 82.77M | 24.16M | 73.84M |
| Capital Expenditures | -1.35M | -1.02M | -331.72K | -61.06K | 0 | -1.46M | -3.2M | -1.69M | -103K |
| CapEx % of Revenue | 0.2% | 0.11% | 0.03% | 0.01% | - | 0.08% | 0.12% | 0.05% | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -607K | 618K | 0 | 0 |
| Cash from Financing | 25.43M | 17.61M | 35.78M | 30.38M | 61.9M | 336.11M | 23.01M | 113.81M | -13.69M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | 1.96K | 14.29K | 3.5K | 1M | 26.69M | 8.4M | -85K | -14.84M | -10.06M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -24.85M | -21.84M | -20.28M | -29.59M | -38.31M | -73.39M | -128.12M | -126.87M | -69.03M |
| FCF Margin % | -3.66% | -2.3% | -1.69% | -2.92% | -4.51% | -4.08% | -4.61% | -3.51% | -2.24% |
| FCF Growth % | - | 0.12% | 0.07% | -0.46% | -0.29% | -0.92% | -0.75% | 0.01% | 0.46% |
| FCF per Share | - | - | -101117.44 | -69728.55 | -216.19 | -155.97 | -260.58 | -218.54 | -36.28 |
| FCF Conversion (FCF/Net Income) | 1.25x | 0.89x | 1.08x | 0.99x | 0.93x | 0.99x | 0.94x | 0.54x | 0.62x |
| Interest Paid | 0 | 0 | 0 | 0 | 1.25M | 1.91M | 298K | 1.65M | 10.65M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -182.46% | -433.64% | -212.46% | -38.92% | -45.21% | -134.56% | -170.33% |
| Return on Invested Capital (ROIC) | - | - | -579.1% | -429.75% | -298.92% | -34.4% | -34.11% | -78.06% | -73.88% |
| Gross Margin | 47.32% | 36.55% | 27.41% | 33.18% | 32.61% | 21.55% | 21.38% | 26.49% | 1.23% |
| Net Margin | -277.48% | -245.82% | -154.13% | -294.34% | -483.43% | -402.84% | -476.93% | -643.74% | -363.98% |
| Debt / Equity | - | - | 0.89x | 5.56x | 0.47x | 0.03x | 0.05x | 0.83x | 0.77x |
| Interest Coverage | -45.03x | -39.29x | -14.78x | -11.32x | -15.30x | -83.17x | -441.94x | -42.05x | -359.80x |
| FCF Conversion | 1.25x | 0.89x | 1.08x | 0.99x | 0.93x | 0.99x | 0.94x | 0.54x | 0.62x |
| Revenue Growth | - | 39.93% | 26.26% | -15.59% | -16.06% | 111.47% | 54.62% | 29.9% | -14.79% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Product | 11.46M | 9.47M | 6.23M | 11.7M | 20.43M | 26.73M | 27.01M |
| Product Growth | - | -17.35% | -34.25% | 87.73% | 74.65% | 30.85% | 1.05% |
| Consumable Revenue | - | 2.71M | 3.14M | 5.81M | 6.73M | 11.16M | 12.77M |
| Consumable Revenue Growth | - | - | 15.96% | 84.69% | 15.89% | 65.76% | 14.48% |
| Instrument Revenue | - | 6.76M | 3.08M | 5.89M | 8.57M | 10M | 8.04M |
| Instrument Revenue Growth | - | - | -54.38% | 90.83% | 45.52% | 16.72% | -19.56% |
| Software Revenue | - | - | - | - | 5.13M | 5.57M | 6.19M |
| Software Revenue Growth | - | - | - | - | - | 8.66% | 11.15% |
| Product and Service, Other | 537.56K | 655.06K | 2.27M | 600K | 700K | 9.39M | 3.77M |
| Product and Service, Other Growth | - | 21.86% | 247.05% | -73.61% | 16.67% | 1241.29% | -59.87% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| EMEA | 3.95M | 3.63M | 3.16M | 5.6M | 8.96M | 12.96M | 14.23M |
| EMEA Growth | - | -8.27% | -12.82% | 77.19% | 59.89% | 44.68% | 9.80% |
| Americas | - | - | - | - | 13.86M | 18.02M | 13.65M |
| Americas Growth | - | - | - | - | - | 30.00% | -24.26% |
| Asia Pacific | 3.45M | 1.47M | 850.93K | 3.05M | 4.98M | 5.13M | 2.89M |
| Asia Pacific Growth | - | -57.36% | -42.18% | 258.20% | 63.39% | 3.07% | -43.64% |
| North America | 4.59M | 5.03M | 4.49M | 9.33M | - | - | - |
| North America Growth | - | 9.48% | -10.75% | 107.80% | - | - | - |
Bionano Genomics, Inc. (BNGO) reported $28.7M in revenue for fiscal year 2024. This represents a 323% increase from $6.8M in 2016.
Bionano Genomics, Inc. (BNGO) saw revenue decline by 14.8% over the past year.
Bionano Genomics, Inc. (BNGO) reported a net loss of $38.6M for fiscal year 2024.
Bionano Genomics, Inc. (BNGO) has a return on equity (ROE) of -170.3%. Negative ROE indicates the company is unprofitable.
Bionano Genomics, Inc. (BNGO) had negative free cash flow of $18.7M in fiscal year 2024, likely due to heavy capital investments.